# Naproxen Sodium/ASA Platelet Study

> **NCT02229461** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 117 (actual)

## Conditions studied

- Hematology

## Interventions

- **DRUG:** Naproxen Sodium (Aleve, BAY117031)
- **DRUG:** Acetylsalicylic Acid (Aspirin, BAYE4465)

## Key facts

- **NCT ID:** NCT02229461
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 117 (ACTUAL)
- **Last updated:** 2016-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02229461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02229461, "Naproxen Sodium/ASA Platelet Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02229461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*